Kamada .(US:KMDA) ZACKS·2025-11-10 14:16Company Performance - Kamada reported quarterly earnings of $0.09 per share, missing the Zacks Consensus Estimate of $0.10 per share, but showing an increase from $0.07 per share a year ago, resulting in an earnings surprise of -10.00% [1] - The company posted revenues of $47.01 million for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 1.64% and increasing from $41.74 million year-over-year [2] - Over the last four quarters, Kamada has surpassed consensus EPS estimates two times and topped consensus revenue estimates two times [2] Stock Outlook - Kamada shares have increased approximately 9.4% since the beginning of the year, compared to the S&P 500's gain of 14.4% [3] - The company's earnings outlook, including current consensus earnings expectations for upcoming quarters, will be crucial for investors [4] - The current consensus EPS estimate for the coming quarter is $0.11 on revenues of $45.85 million, and for the current fiscal year, it is $0.39 on revenues of $180.87 million [7] Industry Context - The Medical - Biomedical and Genetics industry, to which Kamada belongs, is currently in the top 36% of over 250 Zacks industries, indicating a favorable outlook [8] - Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can impact Kamada's stock performance [5][6]